Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice-Reference-Cited by-同舟云学术

Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice

Published:2022-12-21 Issue:6 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Wang Jiaqi¹,Chen Jiahuan¹,Li Linquan¹,Zhang Huanyu¹,Pang Daxin¹,Ouyang Hongsheng¹,Jin Xuemin²,Tang Xiaochun¹³^ORCID

Affiliation:

1. College of Animal Sciences, Jilin University, Changchun, People’s Republic of China

2. State Key Laboratory for Zoonotic Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun China

3. Chongqing Research Institute of Jilin University, Chongqing, People’s Republic of China

Abstract

Cardiac fibrosis is a basic process in cardiac remodeling. It is related to almost all types of cardiovascular diseases (CVD) and has become an important global health problem.

Funder

MOST | National Key Research and Development Program of China

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.02524-22

Reference84 articles.

1. A primer on current progress in cardiac fibrosis

2. Considerations for Clinical Trials Targeting the Myocardial Interstitium

3. Postinfarction Gene Therapy Against Transforming Growth Factor-β Signal Modulates Infarct Tissue Dynamics and Attenuates Left Ventricular Remodeling and Heart Failure